AXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing Gum
07 mars 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, March 07, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced enrollment of 40 patients...
AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum
18 janv. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 18, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating...
AXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD Gum
04 janv. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK)...
AXIM® Biotech Receives Medical Ethical Committee Approval to Begin IBS Trial for Canchew Plus® CBDGum
06 déc. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it received...
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
06 nov. 2014 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's...
Healthy Choices at Every Meal
20 juin 2013 05h00 HE
|
VSL#3
MISSION, KS--(Marketwired - Jun 20, 2013) - (Family Features) For families of the nearly 30 percent of the general population who suffer from irritable bowel syndrome, making healthy diet decisions...
Innovative Med Concepts Debuts Revolutionary iPhone(R) App Designed to Monitor Daily Health Habits and Improve Well-Being
22 mai 2012 08h00 HE
|
Innovative Med Concepts, LLC
TUSCALOOSA, AL--(Marketwire - May 22, 2012) - Privately held Innovative Med Concepts, LLC today announced the availability of UShapeHealth, a new, user-friendly, mobile health application for the...
Novogen's Investigational Drug for Inflammatory Bowel Disease Has Positive Results Following Phase Ib Trial
04 déc. 2007 08h01 HE
|
Novogen, Limited
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed
Phase Ib clinical trial of a new drug to treat inflammatory bowel disease
(IBD) indicates that treatment may...